Literature DB >> 11124823

Wound-induced migration of rat hepatic stellate cells is modulated by endothelin-1 through rho-kinase-mediated alterations in the acto-myosin cytoskeleton.

P Tangkijvanich1, S P Tam, H F Yee.   

Abstract

Although migration of stellate cells during hepatic injury is essential for wound-healing and fibrosis of the liver, the extracellular and intracellular signals that regulate stellate cell migration are incompletely understood. In this study we tested the hypothesis that wound-induced migration of stellate cells is modulated by endothelin-1 (ET-1) through rho-kinase-mediated alterations in the acto-myosin cytoskeleton. To address this hypothesis, a method was established for direct visualization of wound-induced migration of culture-activated stellate cells with subcellular resolution. Migration in response to wounding was characterized by (1) plasma membrane ruffling and protrusion into the wound, (2) lamellipodia formation at the leading edge, (3) focal adhesion and stress fiber assembly, and (4) myosin reorganization. Exogenous ET-1 accelerated wound-induced migration of stellate cells, but did not alter wound-induced proliferation. Experiments using ET-1 antagonists in the absence of exogenous ET-1 showed that wound-induced migration was also stimulated by endogenous ET-1. Selective inhibition of rho-associated kinase decelerated migration in response to wounding. Moreover, inhibition of rho-associated kinase was distinguished by abrogation of focal adhesion formation, stress fiber assembly, and myosin reorganization. This study shows that rho-kinase-dependent alterations in the acto-myosin cytoskeleton contribute to wound-induced stellate cell migration, which is accelerated by both exogenous and endogenous ET-1. Consequently, these results provide important new evidence suggesting that, migration of stellate cells is modulated by paracrine and autocrine ET-1 stimulation via the action of rho-kinase on the acto-myosin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11124823     DOI: 10.1053/jhep.2001.20677

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

Review 1.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.

Authors:  H Reynaert; M G Thompson; T Thomas; A Geerts
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 2.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Cell growth in vitro directed by handmade patterns.

Authors:  Miguel R Reyes; Brissia Lazalde
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Sep-Oct       Impact factor: 2.416

4.  Effects of phased joint intervention on Rho/ROCK expression levels in patients with portal hypertension.

Authors:  Min Shi; Jue Wei; Wen-Ying Meng; Na Wang; Ting Wang; Yu-Gang Wang
Journal:  Exp Ther Med       Date:  2016-06-14       Impact factor: 2.447

5.  Nonmuscle myosin-dependent synthesis of type I collagen.

Authors:  Le Cai; Dillon Fritz; Lela Stefanovic; Branko Stefanovic
Journal:  J Mol Biol       Date:  2010-07-13       Impact factor: 5.469

6.  Endothelin-1 stimulates human colonic myofibroblast contraction and migration.

Authors:  L E Kernochan; B N Tran; P Tangkijvanich; A C Melton; S P Tam; H F Yee
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

7.  Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors.

Authors:  S Ayabe; T Murata; T Maruyama; M Hori; H Ozaki
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 8.  Stellate cell contraction: role, regulation, and potential therapeutic target.

Authors:  Russell K Soon; Hal F Yee
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

9.  Different profiles of Ca2+ responses to endothelin-1 and PDGF in liver myofibroblasts during the process of cell differentiation.

Authors:  N Kojima; M Hori; T Murata; Y Morizane; H Ozaki
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

10.  Rho kinase inhibitors block activation of pancreatic stellate cells.

Authors:  Atsushi Masamune; Kazuhiro Kikuta; Mashiro Satoh; Kennichi Satoh; Tooru Shimosegawa
Journal:  Br J Pharmacol       Date:  2003-10-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.